Enterococcus IVDs

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Verfügbar ab:

Cepheid Holdings Pty Ltd

Klasse:

Class 3

Hergestellt von:

Cepheid AB Rontgenvagen 5, Solna, SE-171 54 Sweden

Therapiebereich:

CT921 - Enterococcus IVDs

Anwendungsgebiete:

The Cepheid Xpert vanA/vanB Assay performed in the GeneXpert System is a qualitative in vitro diagnostic test designed for rapid detection of vancomycin-resistance (vanA/vanB) genes from rectal and perianal swab specimens in patients at risk for intestinal colonization of vancomycin-resistant bacteria. The test utilizes automated real-time polymerase chain reaction (PCR) to detect the vanA and vanB genes that can be associated with vancomycin-resistant enterococci (VRE).

Berechtigungsstatus:

A

Berechtigungsdatum:

2013-04-04